The average pain score was 5.6 on a 0-10 scale, while common side effects that resolved within 1-3 days without intervention included mild edema, mild to moderate erythema, and mild to moderate bruising. No cases of hyperpigmentation, hypopigmentation, blistering, or scarring occurred.
“The newly designed pulsed-dye laser is a major change in a device that has performed for over 10 years with wide acceptance,” Dr. Bernstein said. In addition to a longer-lasting dye kit, he said that new features include 50% more total energy enabling clinically relevant fluences to be delivered using a 15-mm diameter treatment beam, once-daily calibration instead of after every energy or spot size change, “both contact and dynamic spray cooling, and an Nd:YAG wavelength for treating larger vessels.”
Dr. Bernstein reported having received grant funding from Syneron Candela and Zeltiq. He also has received consulting fees from and holds ownership interest in Syneron Candela, and has served on the advisory board for Novoxel, Solta, Syneron Candela, and Zeltiq.